MARKET

ICAD

ICAD

Icad Inc
NASDAQ
3.690
+0.390
+11.82%
After Hours: 3.729 +0.039 +1.05% 17:08 02/05 EST
OPEN
3.370
PREV CLOSE
3.300
HIGH
3.765
LOW
3.200
VOLUME
643.91K
TURNOVER
--
52 WEEK HIGH
3.780
52 WEEK LOW
1.180
MARKET CAP
97.93M
P/E (TTM)
-35.9299
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ICAD last week (0127-0131)?
Weekly Report · 3d ago
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 3d ago
Busy Earnings Season Continues With Alphabet, Disney, Palantir To Report Results
Seeking Alpha · 4d ago
Catalyst Watch: Tariff drama, OPEC+, Alphabet and Amazon earnings, Lennar spinoff
Seeking Alpha · 5d ago
iCAD Shares Climb After 4Q Sales Guidance Beats Expectations
Dow Jones · 01/27 19:12
Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX) and iCAD (ICAD)
TipRanks · 01/27 13:50
iCAD expects Q4 revenue higher than consensus
Seeking Alpha · 01/27 13:26
ICAD Expects Q4 2024 Revenue Between $5.1M-$5.3M; Total Annual Recurring Revenue Reaches $9.8M, Up 11% YoY; Closed 106 Deals, Including 19 Cloud Deals
Benzinga · 01/27 13:07
More
About ICAD
iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a woman’s breast anatomy from the mammogram image.

Webull offers iCAD Inc stock information, including NASDAQ: ICAD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICAD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICAD stock methods without spending real money on the virtual paper trading platform.